Hyperglycemia, inflammatory response and infarct size in obstructive acute myocardial infarction and MINOCA

[1]  A. Manolis,et al.  Myocardial infarction or acute coronary syndrome with non-obstructive coronary arteries and sudden cardiac death: a missing connection , 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[2]  S. Fang,et al.  The association between glucose-related variables and plaque morphology in patients with ST-segment elevated myocardial infarction , 2020, Cardiovascular Diabetology.

[3]  Shuai Meng,et al.  Augmented glycaemic gap is a marker for an increased risk of post-infarct left ventricular systolic dysfunction , 2020, Cardiovascular Diabetology.

[4]  P. Rucci,et al.  Secondary Prevention Medical Therapy and Outcomes in Patients With Myocardial Infarction With Non-Obstructive Coronary Artery Disease , 2020, Frontiers in Pharmacology.

[5]  M. Gnecchi,et al.  Neutrophil to platelet ratio: A novel prognostic biomarker in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention , 2019, European journal of preventive cardiology.

[6]  N. Wong,et al.  Most important advances in preventive cardiology during this past decade: Viewpoint from the American Society for Preventive Cardiology. , 2019, Trends in cardiovascular medicine.

[7]  Y. Hafez,et al.  Incidence, predictors and outcomes of stress hyperglycemia in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention , 2019, Diabetes & vascular disease research.

[8]  A. von Eckardstein,et al.  Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: role of the novel biomarker Cyr 61 , 2019, Cardiovascular diabetology.

[9]  Yaiza Beatriz Molero-Díez,et al.  Fourth universal definition of myocardial infarction , 2019, Colombian Journal of Anesthesiology.

[10]  H. Bøtker,et al.  Impact of hyperglycemia on myocardial ischemia–reperfusion susceptibility and ischemic preconditioning in hearts from rats with type 2 diabetes , 2019, Cardiovascular Diabetology.

[11]  H. Jneid,et al.  Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association , 2019, Circulation.

[12]  R. Esper,et al.  Cardiovascular events, diabetes and guidelines: the virtue of simplicity , 2019, Cardiovascular Diabetology.

[13]  L. Lerman,et al.  Coronary microvascular dysfunction is associated with poor glycemic control amongst female diabetics with chest pain and non-obstructive coronary artery disease , 2019, Cardiovascular Diabetology.

[14]  G. Paolisso,et al.  Effects of Metformin Therapy on Coronary Endothelial Dysfunction in Patients With Prediabetes With Stable Angina and Nonobstructive Coronary Artery Stenosis: The CODYCE Multicenter Prospective Study , 2019, Diabetes Care.

[15]  M. Beijk,et al.  Myocardial infarction with non-obstructive coronary arteries: a focus on vasospastic angina , 2019, Netherlands Heart Journal.

[16]  S. Pocock,et al.  Predictors of all‐cause mortality and ischemic events within and beyond 1 year after an acute coronary syndrome: Results from the EPICOR registry , 2018, Clinical cardiology.

[17]  2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2019 , 2018, Diabetes Care.

[18]  C. Hamm.  [MINOCA-myocardial infarction with non-obstructive coronary arteries]. , 2018, Herz.

[19]  Kristian Thygesen,et al.  Fourth Universal Definition of Myocardial Infarction (2018). , 2018, Journal of the American College of Cardiology.

[20]  Y. Zhang,et al.  Neutrophil to lymphocyte ratio as a predictor of myocardial damage and cardiac dysfunction in acute coronary syndrome patients , 2018, Integrative medicine research.

[21]  Marco Valgimigli,et al.  [2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.] , 2018, Kardiologia polska.

[22]  S. Pocock,et al.  Predicting two-year mortality from discharge after acute coronary syndrome: An internationally-based risk score , 2019, European heart journal. Acute cardiovascular care.

[23]  D. Cruz-Topete,et al.  Hypothalamic-Pituitary-Adrenal Axis Modulation of Glucocorticoids in the Cardiovascular System , 2017, International journal of molecular sciences.

[24]  G. Su,et al.  Comparison of in-hospital glycemic variability and admission blood glucose in predicting short-term outcomes in non-diabetes patients with ST elevation myocardial infarction underwent percutaneous coronary intervention , 2017, Diabetology & Metabolic Syndrome.

[25]  Qianqian Liu,et al.  Platelet to lymphocyte ratio in the prediction of adverse outcomes after acute coronary syndrome: a meta-analysis , 2017, Scientific Reports.

[26]  D. Atar,et al.  ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. , 2016, European heart journal.

[27]  Hui Li,et al.  The prognostic value of the platelet-to-lymphocyte ratio in acute coronary syndrome: a systematic review and meta-analysis. , 2017, Kardiologia polska.

[28]  L. Manzoli,et al.  Nonobstructive Versus Obstructive Coronary Artery Disease in Acute Coronary Syndrome: A Meta‐Analysis , 2016, Journal of the American Heart Association.

[29]  K. Nagashima,et al.  A comparative study of time-specific oxidative stress after acute myocardial infarction in patients with and without diabetes mellitus , 2016, BMC Cardiovascular Disorders.

[30]  O. Centurión.  Serum biomarkers and source of inflammation in acute coronary syndromes and percutaneous coronary interventions. , 2016, Cardiovascular revascularization medicine : including molecular interventions.

[31]  G. Reboldi,et al.  Hyperglycemia in acute coronary syndromes: from mechanisms to prognostic implications , 2015, Therapeutic advances in cardiovascular disease.

[32]  M. Arstall,et al.  Meta-analysis of admission hyperglycaemia in acute myocardial infarction patients treated with primary angioplasty: a cause or a marker of mortality? , 2015, European heart journal. Cardiovascular pharmacotherapy.

[33]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, European heart journal cardiovascular Imaging.

[34]  Amicia D Elliott,et al.  Metabolic Control by Inflammation and Immunity Interleukin-6 amplifies glucagon secretion : coordinated control via the brain and pancreas , 2014 .

[35]  H. Bøtker,et al.  Impact of Acute Hyperglycemia on Myocardial Infarct Size, Area at Risk, and Salvage in Patients With STEMI and the Association With Exenatide Treatment: Results From a Randomized Study , 2014, Diabetes.

[36]  P. Marik,et al.  Stress hyperglycemia: an essential survival response! , 2013, Critical Care.

[37]  S. Agewall,et al.  Myocardial infarction with normal coronary arteries is common and associated with normal findings on cardiovascular magnetic resonance imaging: results from the Stockholm Myocardial Infarction with Normal Coronaries study , 2013, Journal of internal medicine.

[38]  Dhiren P. Shah,et al.  ON OXIDATIVE STRESS AND DIABETIC COMPLICATIONS , 2013 .

[39]  G. Schuler,et al.  Prognostic Impact of Hyperglycemia in Nondiabetic and Diabetic Patients With ST-Elevation Myocardial Infarction: Insights From Contrast-Enhanced Magnetic Resonance Imaging , 2012, Circulation. Cardiovascular imaging.

[40]  D. Atar,et al.  ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation , 2013 .

[41]  Binita Shah,et al.  Hyperglycemia in Nondiabetic Patients Presenting With Acute Myocardial Infarction , 2012, The American journal of the medical sciences.

[42]  I. Guney,et al.  The Relationship Between Neutrophil-to-Lymphocyte Ratio and Inflammation in End-Stage Renal Disease Patients , 2012, Renal failure.

[43]  J. Ottervanger,et al.  Prognostic Value of Admission Glycosylated Hemoglobin and Glucose in Nondiabetic Patients With ST-Segment–Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention , 2011, Circulation.

[44]  E. Bacha,et al.  Disease: A Scientific Statement From the American Heart Association Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac , 2011 .

[45]  Ferdinando Giacco,et al.  Oxidative stress and diabetic complications. , 2010, Circulation research.

[46]  E. Boersma,et al.  Elevated admission glucose is associated with increased long-term mortality in myocardial infarction patients, irrespective of the initially applied reperfusion strategy. , 2010, American heart journal.

[47]  D. Nathan,et al.  Hyperglycemia on admission predicts larger infarct size in patients undergoing percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. , 2010, Diabetes research and clinical practice.

[48]  M. Cheitlin.  Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponin-positive patients without coronary artery disease , 2010 .

[49]  K. Klingel,et al.  Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponin-positive patients without coronary artery disease. , 2009, European heart journal.

[50]  K. Ley,et al.  Immune and inflammatory mechanisms of atherosclerosis (*). , 2009, Annual review of immunology.

[51]  P. Raskin,et al.  Hyperglycemia and Acute Coronary Syndrome: A Scientific Statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism , 2008, Anesthesiology.

[52]  P. Raskin,et al.  Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. , 2008, Circulation.

[53]  K. Rock,et al.  The inflammatory response to cell death. , 2008, Annual review of pathology.

[54]  VA Stephen E. Borst Ph.D..  The role of TNF-α in insulin resistance , 2007, Endocrine.

[55]  Y. Le Marchand-Brustel,et al.  Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. , 2007, Endocrinology.

[56]  S. Borst.  The role of TNF-alpha in insulin resistance. , 2004, Endocrine.

[57]  R. Marfella,et al.  Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome. , 2003, Diabetes care.

[58]  H. Gerstein,et al.  Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview , 2000, The Lancet.

[59]  B. Lin,et al.  Hyperglycemia triggers massive neutrophil deposition in brain following transient ischemia in rats , 2000, Neuroscience Letters.